March 12, 2007 — The US Food and Drug Administration (FDA) has granted 510(k) clearance for a device intended to provide ventilatory support for patients with sleep apnea, a data management system for ...

Co announces that the FDA granted 510(k) clearance of the BiPAP autoSV device, which is intended to provide noninvasive ventilatory support to treat adult patients with Obstructive Sleep Apnea and ...

MURRYSVILLE, Pa., March 7 (UPI) -- U.S. firm Respironics said Wednesday it has been cleared to sell its BiPAP autoSV device to treat breathing problems in sleep-disordered patients. The device ...

March 7 (Reuters) - Respironics Inc. said U.S. regulators granted approval to market its ventilatory support device, BiPAP autoSV, for sleep-disordered breathing patients. The company said the device ...

Philips to highlight the Dream Family connected therapy system, announcing its extension with the introduction of BiPAP autoSV and BiPAP AVAPS therapy devices Philips Respironics, a division of Royal ...

Breathing machines with adaptive servo-ventilation (ASV) did not improve survival or other clinical outcomes in patients with heart failure (HF) and reduced ejection fraction and sleep-disordered ...

On May 15, 2015, Respironics, Inc., a Philips business, provided the following response to ResMed's Update on Phase IV SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy in Central Sleep Apnea ...

Royal Philips ($PHG) said it is working with ResMed ($RMD) to analyze study data from mid-May showing that the latter company's Adaptive Servo-Ventilation (ASV ...

Philips Respironics, a division of Royal Philips (NYSE: PHG, AEX: PHIA), will showcase its portfolio of connected sleep and respiratory solutions at the European Respiratory Society (ERS) ...

Philips to highlight the Dream Family connected therapy system, announcing its extension with the introduction of BiPAP autoSV and BiPAP AVAPS therapy devices Philips Respironics, a division of Royal ...